Holen Sie sich die Stockscreener-App
46.83
1.34%
-0.6023
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
FY2030 EPS Estimates for Scholar Rock Raised by Analyst - MarketBeat
Fisher Asset Management LLC Has $19.86 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock at TD Cowen Conference: Strategic Vision and Challenges - Investing.com Nigeria
Piper Sandler raises Scholar Rock stock price target on SMA launch - Investing.com India
SRRK: Citigroup Raises Price Target to $58, Maintains Buy Rating | SRRK Stock News - GuruFocus
Citigroup Issues Positive Forecast for Scholar Rock (NASDAQ:SRRK) Stock Price - MarketBeat
Scholar Rock Holding (SRRK) Sees Price Target Raised by Truist S - GuruFocus
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat
Piper Sandler Raises Price Target for SRRK to $58.00, Maintains Overweight Rating | SRRK Stock News - GuruFocus
Scholar Rock (NASDAQ:SRRK) Sees Unusually-High Trading Volume Following Earnings Beat - MarketBeat
Barclays Raises Price Target for Scholar Rock Holding (SRRK) to $53 | SRRK Stock News - GuruFocus
Piper Sandler Forecasts Strong Price Appreciation for Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Truist Raises Price Target on Scholar Rock Holding to $55 From $44, Keeps Buy Rating - marketscreener.com
Aisling Capital Management LP Takes $2.87 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Decoding Scholar Rock Holding Corp (SRRK): A Strategic SWOT Insi - GuruFocus
SRRK Technical Analysis & ETF Price Forecast - Intellectia AI
Raymond James Maintains Strong Buy on Scholar Rock (SRRK) Mar 2026 - Meyka
Scholar Rock (NASDAQ: SRRK) posts 2025 loss, expands debt capacity - Stock Titan
Barclays raises Scholar Rock stock price target to $53 on debt deal - Investing.com
Scholar Rock (SRRK) Revises Financial Results for Q4 2025 - GuruFocus
Truist raises Scholar Rock stock price target on manufacturing progress By Investing.com - Investing.com Australia
Truist raises Scholar Rock stock price target on manufacturing progress - Investing.com
Raymond James reiterates Scholar Rock stock Strong Buy on debt facility - Investing.com
Scholar Rock Q4 Earnings Call Highlights - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Gap UpTime to Buy? - MarketBeat
Scholar Rock Q4 2025 Earnings Call Transcript - MarketBeat
Scholar Rock Holding (SRRK) Receives Reiterated 'Buy' Rating fro - GuruFocus
Scholar Rock (NASDAQ:SRRK) Given Buy Rating at HC Wainwright - MarketBeat
Scholar Rock Holding Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Wedbush Adjusts Price Target on Scholar Rock to $56 From $50, Maintains Outperform Rating - marketscreener.com
Earnings call transcript: Scholar Rock Q4 2025 shows slight EPS beat, stock rises - Investing.com
Scholar Rock (SRRK) Q4 2025 Earnings Transcript - AOL.com
Scholar Rock Holding Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Scholar Rock (SRRK) Poised for FDA Resubmission of Apitegromab - GuruFocus
Vanguard Group Inc. Has $183.03 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (NASDAQ:SRRK) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026 - ChartMill
Scholar Rock FY income from operations USD -384.645 million - marketscreener.com
Scholar Rock Advances Apitegromab Toward SMA Commercial Launch - TipRanks
Scholar Rock (SRRK) 2025 loss widens as SMA programs advance - Stock Titan
Scholar Rock Holding 10-K: Operating loss $384.6M, Net loss $377.9M - TradingView
Scholar Rock Q4 Net Loss Widens - marketscreener.com
SRRKForm S-8Securities to be offered to employees in employee benefit plans - ADVFN Ltd
Earnings Flash (SRRK) Scholar Rock Posts Q4 Net Loss $0.88 a Share, vs. FactSet Est of $0.89 Loss - marketscreener.com
Apitegromab and SRK-439 lead Scholar Rock (NASDAQ: SRRK) neuromuscular pipeline - Stock Titan
Scholar Rock Holding: Q4 Earnings Insights - Benzinga
Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Stock Titan
Scholar Rock Holding Corporation $SRRK Shares Purchased by Rafferty Asset Management LLC - MarketBeat
SRRK Earnings History & Surprises | EPS & Revenue Results | SCHOLAR ROCK HOLDING CORP (NASDAQ:SRRK) - ChartMill
Scholar Rock investors brace for earnings amid FDA resubmission push By Investing.com - Investing.com UK
Earnings Preview For Scholar Rock Holding - Benzinga
What is the next catalyst for Scholar Rock Holding CorporationPortfolio Return Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Has $26.59 Million Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK Should I Buy - Intellectia AI
Scholar Rock’s New FORGE Study Puts Apitegromab to the Test in FSHD - TipRanks
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages - MarketBeat
Qatanani, Scholar Rock CSO, sells $399k in SRRK stock - Investing.com India
Qatanani, Scholar Rock CSO, sells $399k in SRRK stock By Investing.com - Investing.com South Africa
Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 8,484 Shares - MarketBeat
Insider Sell: Mo Qatanani Sells 8,484 Shares of Scholar Rock Hol - GuruFocus
[Form 4] Scholar Rock Holding Corp Insider Trading Activity - Stock Titan
Assessing Scholar Rock Holding (SRRK) Valuation After Strong Recent Share Performance - simplywall.st
Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and 7.12% Upside Potential - DirectorsTalk Interviews
Scholar Rock Stock Pops On SMA Drug Data: Smart Buy Or Biotech Trap? - AD HOC NEWS
Scholar Rock (SRRK) to Release Quarterly Earnings on Tuesday - MarketBeat
Assessing Scholar Rock (SRRK) Valuation After Recent Share Pullback And Conflicting P/B And DCF Signals - Yahoo Finance
3.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):